Thrive
develops a liquid biopsy-based testing platform that offers early-stage cancer detection solutions to physicians... Read moreThrive
develops a liquid biopsy-based testing platform that offers early-stage cancer detection solutions to physicians... Read more
CEO
David J. Daly
2019
PrivateAcquired by Exact Sciences Corp.
News
Jan 05, 2021
The Business Journals: Greensboro/Winston-Salem/High Point
Thrive Earlier Detection Corp.: Exact Sciences finalizes $2.15B acquisition of Thrive Earlier Detection
Nov 28, 2020
Global Legal Chronicle
Thrive: Exact Sciences' $869.2 Million Common Stock Offering
Nov 03, 2020
The Business Journals: Boston
Thrive: Here's why a cancer-testing startup agreed to a $2.1B buyout
Oct 27, 2020
Business Insider
Thrive: Exact Sciences soars 33% after agreeing to acquire early cancer detection firm for $2.15 billion
Oct 27, 2020
Journal Sentinel
Thrive: Exact Sciences acquires two companies to expand its cancer screening
Oct 27, 2020
Endpoints News
Thrive: A month after Illumina's big Grail buyout, Exact Sciences scoops up liquid biopsy rival Thrive for a relative bargain
Oct 27, 2020
Global University Venturing
Thrive: Thrive Earlier Detection scores $2.15bn exit - Global University Venturing
Sep 30, 2020
Boston Citybizlist
Thrive: Thrive Earlier Detection Strengthens Leadership Team
Aug 03, 2020
The Business Journals: Greensboro/Winston-Salem/High Point
Thrive Earlier Detection: Exact Sciences ups investment in Massachusetts cancer blood-testing firm
Jul 31, 2020
Global Legal Chronicle
Thrive Earlier Detection: Thrive Earlier Detection Corp's $257 Million Series B Financing
Thrive Competitors
1
2
3
4
5
6
7
8
9
10